DE60307109D1 - Verfahren zur herstellung von zolmitriptanverbindungen - Google Patents

Verfahren zur herstellung von zolmitriptanverbindungen

Info

Publication number
DE60307109D1
DE60307109D1 DE60307109T DE60307109T DE60307109D1 DE 60307109 D1 DE60307109 D1 DE 60307109D1 DE 60307109 T DE60307109 T DE 60307109T DE 60307109 T DE60307109 T DE 60307109T DE 60307109 D1 DE60307109 D1 DE 60307109D1
Authority
DE
Germany
Prior art keywords
give
viii
compound
zolmitriptan
pyranoindolone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60307109T
Other languages
English (en)
Other versions
DE60307109T2 (de
Inventor
Barjoan Pere Dalmases
Asparo Montserrat Armengol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inke SA
Original Assignee
Inke SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inke SA filed Critical Inke SA
Application granted granted Critical
Publication of DE60307109D1 publication Critical patent/DE60307109D1/de
Publication of DE60307109T2 publication Critical patent/DE60307109T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Colloid Chemistry (AREA)
DE60307109T 2002-08-07 2003-08-05 Verfahren zur herstellung von zolmitriptanverbindungen Expired - Fee Related DE60307109T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200201873 2002-08-07
ES200201873A ES2204302B2 (es) 2002-08-07 2002-08-07 Procedimiento para la obtencion de un compuesto farmaceuticamente activo.
PCT/IB2003/003536 WO2004014901A1 (en) 2002-08-07 2003-08-05 Process for preparing zolmitriptan compounds

Publications (2)

Publication Number Publication Date
DE60307109D1 true DE60307109D1 (de) 2006-09-07
DE60307109T2 DE60307109T2 (de) 2007-02-15

Family

ID=31502893

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60307109T Expired - Fee Related DE60307109T2 (de) 2002-08-07 2003-08-05 Verfahren zur herstellung von zolmitriptanverbindungen

Country Status (11)

Country Link
US (2) US7342035B2 (de)
EP (1) EP1534705B1 (de)
KR (1) KR100753353B1 (de)
AT (1) ATE334126T1 (de)
AU (1) AU2003250476A1 (de)
DE (1) DE60307109T2 (de)
ES (2) ES2204302B2 (de)
IS (1) IS2333B (de)
NO (1) NO20051178L (de)
TW (1) TW200404059A (de)
WO (1) WO2004014901A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2204302B2 (es) * 2002-08-07 2005-03-01 Laboratorios Vita, S.A. Procedimiento para la obtencion de un compuesto farmaceuticamente activo.
EP1711493A2 (de) * 2004-02-06 2006-10-18 CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement Kristalline formen von zolmitriptan
US20050245585A1 (en) * 2004-04-22 2005-11-03 Islam Aminul Process for preparing optically pure zolmitriptan
EP1799675A4 (de) * 2004-04-22 2010-04-28 Reddys Lab Ltd Dr Verfahren zur herstellung von optisch reinem zolmitriptan
WO2006055964A2 (en) * 2004-11-19 2006-05-26 Teva Pharmaceutical Industries Ltd. Zolmitriptan crystal forms
ES2270717B1 (es) * 2005-08-08 2008-03-01 Ragactives, S.L. Procedimiento para la obtencion de derivados de triptamina.
ATE510836T1 (de) * 2006-01-19 2011-06-15 Matrix Lab Ltd Umwandlung eines aromatischen diazoniumsalzes in ein arylhydrazin
JP2010540613A (ja) 2007-10-03 2010-12-24 ジェネリクス・（ユーケー）・リミテッド ゾルミトリプタン、その塩、及びその溶媒和物の調製方法
US8343381B1 (en) 2008-05-16 2013-01-01 E I Du Pont De Nemours And Company Hole transport composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2160736C2 (ru) 1990-06-07 2000-12-20 Зенека Лимитед Производные индола и их физиологически приемлемые соли и сольваты, способы их получения, лекарственное средство для лечения или профилактики клинических состояний, для которых показан прием агониста "5-нт1-подобного" рецептора, и способ его получения
JPH05507701A (ja) * 1990-06-07 1993-11-04 スミスクライン・ビーチャム・コーポレイション ロイコトリエン関連疾患治療用フタルアミド酸およびその異性体
GB9516145D0 (en) * 1995-08-07 1995-10-04 Wellcome Found Improved chemical synthesis
US5998438A (en) * 1996-11-26 1999-12-07 Allelix Biopharmaceuticals, Inc. 5-cyclo indole compounds
ES2204302B2 (es) * 2002-08-07 2005-03-01 Laboratorios Vita, S.A. Procedimiento para la obtencion de un compuesto farmaceuticamente activo.
ES2204303B2 (es) * 2002-08-07 2004-12-16 Laboratorios Vita, S.A. Procedimiento para la obtencion de un compuesto farmaceuticamente activo.

Also Published As

Publication number Publication date
US20060025600A1 (en) 2006-02-02
EP1534705A1 (de) 2005-06-01
AU2003250476A1 (en) 2004-02-25
TW200404059A (en) 2004-03-16
NO20051178L (no) 2005-03-04
ATE334126T1 (de) 2006-08-15
ES2204302B2 (es) 2005-03-01
ES2270144T3 (es) 2007-04-01
KR100753353B1 (ko) 2007-08-30
IS2333B (is) 2008-02-15
KR20050060061A (ko) 2005-06-21
EP1534705B1 (de) 2006-07-26
US20080306279A1 (en) 2008-12-11
US7342035B2 (en) 2008-03-11
WO2004014901A1 (en) 2004-02-19
US7563904B2 (en) 2009-07-21
DE60307109T2 (de) 2007-02-15
IS7703A (is) 2005-02-21
ES2204302A1 (es) 2004-04-16

Similar Documents

Publication Publication Date Title
IS7703A (is) Aðferð til að framleiða solmítriptanefnasambönd
NO20051155L (no) Fremgangsmate for fremstilling av en farmasoytisk aktiv forbindelse
CY1112283T1 (el) Μεθοδος για την παρασκευη 17-βινυλ-τριφλικων ως ενδιaμεσα
RS20100169A (en) INTERMEDIATES FOR DIOXAN-2-ALKYLCARBAMATE
ECSP077167A (es) Nuevos compuestos heterociclicos
NO20071253L (no) Fremgangsmate for syntese av C-2, C-3 substituerte N-alkylerte indoler anvendbare som CPLA2-inhibitorer.
DE602006005349D1 (de) Verfahren zur herstellung von hydrazon-derivaten
BR112012021749B1 (pt) processos para a preparação de um composto e composto benzilamina
EA200700767A1 (ru) Способ получения пиразолов
BRPI0415002A (pt) processo para preparação de compostos heterocìclicos n-amino substituìdos
WO2009047797A3 (en) Process for the preparation of perhydroisoindole derivative
TW200612912A (en) Benzyloxy derivatives as maob inhibitors
WO2004041781A8 (en) Preparation of 3-aminoalkyl-substituted indole derivatives from phenylhydrazines and aminoketones
Bensel et al. Straightforward synthesis of N-protected benzylic amines by carbamoalkylation of aromatic compounds
DE60306636D1 (de) Wachstumhormonsekretionsförderer
SaeedáGulzar Enantiospecific conjugate addition of N-nucleophiles to substituted fumaric acids using methylasparase
CY1116177T1 (el) Μεθοδος για την παρασκευη 17-βινυλο-τριφλικων ως ενδιαμεσα
EE04587B1 (et) 1-(aminometüül)tsükloheksüüläädikhappe sünteesi protsess
DK1581504T3 (da) Fremgangsmåde til fremstilling af subsituterede imidazolderivater og intermediater anvendt i fremgangsmåden
ES2270717B1 (es) Procedimiento para la obtencion de derivados de triptamina.
DE602006006334D1 (de) Verfahren zur herstellung von aminosäurederivaten
TH78688A (th) กรรมวิธีสำหรับการเตรียมไพราโซล
FR2854632B1 (fr) Synthese de composes heterocycliques substitues
JPS5849543B2 (ja) ピラゾ−ルユウドウタイノセイホウ
HK1085459A1 (en) Process for the synthesis of peptides containing a 4-hydroxy-proline substructure

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee